Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
Gill D, Burgess S, 2020, Use of a genetic variant related to circulating factor Xa levels to proxy the effect of factor Xa Inhibition on cardiovascular outcomes, Circulation: Genomic and Precision Medicine, ISSN:2574-8300
et al., 2020, Genetically predicted circulating concentrations of micro-nutrients and risk of breast cancer: A Mendelian randomization study, International Journal of Cancer, ISSN:0020-7136
et al., 2020, Genetically determined blood pressure, antihypertensive drug classes and risk of stroke subtypes, Neurology, Vol:95, ISSN:0028-3878, Pages:e353-361
et al., 2020, A Mendelian randomization of γ' and total fibrinogen levels on venous thromboembolism and ischemic stroke., Blood
et al., 2020, Genetically predicted midlife blood pressure and coronary artery disease risk: Mendelian randomization analysis, Journal of the American Heart Association, Vol:9, ISSN:2047-9980